Table 2.
Author | Year | A | B | C | D | E | F | G | H | NOS Score |
---|---|---|---|---|---|---|---|---|---|---|
Moss | 2000 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 7 |
Moutzouri | 2008 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 7 |
Stegenga | 2010 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
Schuetz | 2011 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 6 |
Yang | 2011 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 6 |
Schuetz | 2012 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 6 |
Chang | 2012 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 6 |
Al-Dorzi | 2012 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 6 |
Venot | 2015 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 8 |
De Miguel-Yanes | 2015 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 6 |
A – Representativeness of the exposed cohort; B – selection of the non-exposed cohort; C – ascertainment of exposure; D – demonstration that outcome of interest was not present at start of study; E – comparability of cohorts on the basis of the design or analysis; F – assessment of outcome; G – was follow-up long enough for outcomes to occur?; H – adequacy of follow-up of cohorts.